Submitted by Anonymous (not verified) on 29 September 2023 - 15:04
Human medicines European public assessment report (EPAR): Locametz, gozetotide, Radionuclide Imaging, Date of authorisation: 09/12/2022, Revision: 2, Status: Authorised
Source: